regulatory
confidence high
sentiment negative
materiality 0.65
Glucotrack, Inc. (GCTK): Nasdaq/NYSE listing notice — Glucotrack gets 180-day Nasdaq extension to May 20, 2024 to regain $1.00 bid price compliance
Glucotrack, Inc.
- Received Nasdaq letter on Nov 24, 2023 granting additional 180 days until May 20, 2024 to meet minimum $1.00 bid price requirement.
- Must have closing bid price of at least $1.00 for 10 consecutive business days to regain compliance.
- Company may consider a reverse stock split if needed to cure the deficiency.
- Trading continues on Nasdaq Capital Market under symbol GCTK with no immediate effect on listing.